Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells.

Rachubinski AL, Maclean KN, Evans JR, Bjugstad KB.

Exp Gerontol. 2012 Sep;47(9):723-33. doi: 10.1016/j.exger.2012.06.013. Epub 2012 Jul 7.

PMID:
22776132
2.

Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.

Kern DS, Maclean KN, Jiang H, Synder EY, Sladek JR Jr, Bjugstad KB.

Cell Transplant. 2011;20(3):371-9. doi: 10.3727/096368910X528085. Epub 2010 Sep 27.

PMID:
20875225
3.

Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of Down syndrome.

Rachubinski AL, Crowley SK, Sladek JR Jr, Maclean KN, Bjugstad KB.

PLoS One. 2012;7(4):e36082. doi: 10.1371/journal.pone.0036082. Epub 2012 Apr 25.

4.

Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.

Velazquez R, Ash JA, Powers BE, Kelley CM, Strawderman M, Luscher ZI, Ginsberg SD, Mufson EJ, Strupp BJ.

Neurobiol Dis. 2013 Oct;58:92-101. doi: 10.1016/j.nbd.2013.04.016. Epub 2013 Apr 30.

5.

Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.

Stagni F, Giacomini A, Guidi S, Ciani E, Ragazzi E, Filonzi M, De Iasio R, Rimondini R, Bartesaghi R.

Neurobiol Dis. 2015 Feb;74:204-18. doi: 10.1016/j.nbd.2014.12.005. Epub 2014 Dec 10.

PMID:
25497735
6.

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

Faizi M, Bader PL, Tun C, Encarnacion A, Kleschevnikov A, Belichenko P, Saw N, Priestley M, Tsien RW, Mobley WC, Shamloo M.

Neurobiol Dis. 2011 Aug;43(2):397-413. doi: 10.1016/j.nbd.2011.04.011. Epub 2011 Apr 17.

7.

Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.

Pollonini G, Gao V, Rabe A, Palminiello S, Albertini G, Alberini CM.

Neuroscience. 2008 Sep 22;156(1):99-106. doi: 10.1016/j.neuroscience.2008.07.025. Epub 2008 Jul 25.

8.

Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.

Lockrow J, Boger H, Bimonte-Nelson H, Granholm AC.

Behav Brain Res. 2011 Aug 10;221(2):610-22. doi: 10.1016/j.bbr.2010.03.036. Epub 2010 Apr 2.

10.

The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.

Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC.

J Neurosci. 2009 May 6;29(18):5938-48. doi: 10.1523/JNEUROSCI.1547-09.2009.

11.

Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.

Granholm AC, Ford KA, Hyde LA, Bimonte HA, Hunter CL, Nelson M, Albeck D, Sanders LA, Mufson EJ, Crnic LS.

Physiol Behav. 2002 Nov;77(2-3):371-85.

PMID:
12419414
12.

Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.

Rueda N, Llorens-Martín M, Flórez J, Valdizán E, Banerjee P, Trejo JL, Martínez-Cué C.

J Alzheimers Dis. 2010;21(1):277-90. doi: 10.3233/JAD-2010-100240.

PMID:
20421694
13.

Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.

Hunter CL, Bimonte-Nelson HA, Nelson M, Eckman CB, Granholm AC.

Neurobiol Aging. 2004 Aug;25(7):873-84.

PMID:
15212841
14.

The Ts65Dn mouse model of Down syndrome shows reduced expression of the Bcl-X(L) antiapoptotic protein in the hippocampus not accompanied by changes in molecular or cellular markers of cell death.

Rueda N, Flórez J, Martínez-Cué C.

Int J Dev Neurosci. 2011 Nov;29(7):711-6. doi: 10.1016/j.ijdevneu.2011.06.001. Epub 2011 Jun 12.

PMID:
21684326
15.

Dentate gyrus mediates cognitive function in the Ts65Dn/DnJ mouse model of Down syndrome.

Smith GK, Kesner RP, Korenberg JR.

Hippocampus. 2014 Mar;24(3):354-62. doi: 10.1002/hipo.22229. Epub 2013 Dec 13.

16.

Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.

Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H, Joels M, van Leuven F, Lucassen PJ.

J Neurosci. 2006 Mar 29;26(13):3514-23.

17.

Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.

Frye CA, Walf AA.

Neurobiol Learn Mem. 2008 Jan;89(1):17-26. Epub 2007 Nov 7.

PMID:
17988898
18.

On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.

Galdzicki Z, Siarey R, Pearce R, Stoll J, Rapoport SI.

Brain Res Brain Res Rev. 2001 Apr;35(2):115-45. Review.

PMID:
11336779
19.

Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice.

Pennanen L, Wolfer DP, Nitsch RM, Götz J.

Genes Brain Behav. 2006 Jul;5(5):369-79.

20.

Supplemental Content

Support Center